171 results
2020 IBD advocacy in review
Despite 2020 being a difficult year due to the COVID-19 pandemic, the Foundation saw some great advocacy successes. These could not have been achieved without the efforts of our advocacy volunteers from across the country as well as the leadership of our congressional champions, including the Congre...
Read more... Throwing light on a potential new treatment for ulcerative proctitis
On November 17-18, 2020, the Crohn’s & Colitis Foundation hosted its third annual IBD Innovate: Product Development for Crohn’s & Colitis™ conference. This meeting brings together researchers, start-up companies, industry companies, accelerator organizations and more who are commit...
Read more... Providing a brighter future in pediatric Crohn’s disease
On November 17-18, 2020, the Crohn’s & Colitis Foundation hosted its third annual IBD Innovate: Product Development for Crohn’s & Colitis™ conference. This meeting brings together researchers, start-up companies, industry companies, accelerator organizations and more who are committed t...
Read more... Improving patient & provider education about biosimilars
When biosimilars first entered the market five years ago, I was excited about new treatment options for patients and for more competition to be created in the market. In the years since, we have seen seven biosimilars approved by the U.S. Food & Drug Administration for IBD indications. But despi...
Read more... Why Crohn’s disease & ulcerative colitis awareness matters
For the past nine years, December 1-7 has been observed across the United States as Crohn’s & Colitis Awareness Week. Originally designated by the passage of U.S. Senate Resolution 199, Awareness Week provides an opportunity for the inflammatory bowel disease (IBD) community to come together aro...
Read more... Research updates about COVID-19 and IBD
COVID-19 has brought uncertainty and question around the world, but especially for those living with Crohn’s disease or ulcerative colitis. With COVID-19 spiking again around the country, we wanted to remind you what we already know about IBD and COVID-19 and share with you some of the latest r...
Read more... Overcoming mental low points during the COVID-19 pandemic
Back in mid-March, as COVID-19 swept the globe, I remember sitting at my favorite cafe in Munich, drinking a cup of coffee and thinking, “tomorrow is lock down and I can’t get coffee.” I never thought I would be stuck in my apartment in a foreign country with only a few months supply of IBD medicati...
Read more... Learning to advocate for myself as an IBD patient
Making hard decisions and advocating for what is best for me is all part of being an IBD patient. Growing up, I was knocked down by this disease countless times and had to advocate for second opinions or treatment plans that would improve my quality of life and help me achieve remission. Throughout ...
Read more... What makes someone an IBD expert
Have you ever wondered what makes someone an inflammatory bowel disease (IBD) expert? Some have described it as, “You know one when you see one.” However, there hasn’t been a set definition of what it truly means. The Crohn’s & Colitis Foundation and the American College of Gastroenterology...
Read more...